ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery

May 16, 2020

Denise Visco, MD, speaks with

Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia following cataract surgery, during the 2020 ASCRS virtual meeting.


See more ASCRS coverage content here